Publications

Sardu, Celestino, Gaetano Santulli, Germano Guerra, Maria Consiglia Trotta, Matteo Santamaria, Cosimo Sacra, Nicola Testa, et al. “Modulation of SERCA in Patients With Persistent Atrial Fibrillation Treated by Epicardial Thoracoscopic Ablation: The CAMAF Study”. Journal of Clinical Medicine 9, no. 2 (2020): 544.

Santulli, Gaetano. “In Acute HF, Intensive and Sustained Vasodilation Did Not Reduce a Composite of Death or HF Readmission at 180 Days”. Annals of Internal Medicine 172, no. 10 (2020): JC54.

Morelli, Marco B, Gaetano Santulli, and Jessica Gambardella. “Calcium Supplements: Good for the Bone, Bad for the Heart? A Systematic Updated Appraisal”. Atherosclerosis 296 (2020): 68-73.

Morelli, Marco Bruno, Christopher Chavez, and Gaetano Santulli. “Angiopoietin-Like Proteins As Therapeutic Targets for Cardiovascular Disease: Focus on Lipid Disorders”. Expert Opinion on Therapeutic Targets 24, no. 1 (2020): 79-88.

Santulli, Gaetano. “In AF and Stable CAD, Rivaroxaban Reduced Cardiovascular Events and Mortality More Than Rivaroxaban Plus an Antiplatelet”. Annals of Internal Medicine 172, no. 2 (2020): JC6.

Wang, Xujun, Marco Bruno Morelli, Alessandro Matarese, Celestino Sardu, and Gaetano Santulli. “Cardiomyocyte-Derived Exosomal MicroRNA-92a Mediates Post-Ischemic Myofibroblast Activation Both in Vitro and Ex Vivo”. ESC Heart Failure 7, no. 1 (2020): 285-89.

Sardu, Celestino, Jessica Gambardella, Marco Bruno Morelli, Xujun Wang, Raffaele Marfella, and Gaetano Santulli. “Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence”. Journal of Clinical Medicine 9, no. 5 (2020): 1417.

Santulli, Gaetano, ed. CARDIOVASCULAR DISEASE AND DIABETES: A JOURNEY FORM BENCH TO BEDSIDE. Frontiers, 2019.

Morelli, Marco B, Jun Shu, Celestino Sardu, Alessandro Matarese, and Gaetano Santulli. “Cardiosomal MicroRNAs Are Essential in Post-Infarction Myofibroblast Phenoconversion”. International Journal of Molecular Sciences 21, no. 1 (2019): 201.

Santulli, Gaetano. “Catheter Ablation Improved Quality of Life More Than Drug Therapy at 1 Y in Symptomatic Atrial Fibrillation”. Annals of Internal Medicine 171, no. 2 (2019): JC9.